Ignite Creation Date:
2024-07-17 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06494189
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-02
Brief Title:
Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
Sponsor:
West China Hospital
Organization:
West China Hospital
Organization Data
Organization:
West China Hospital
Class:
OTHER
Study ID:
2024-795
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
West China Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Xingchen Peng
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
West China Hospital
Old Name:
None
Old Organization:
None